Hi, Daytime Respert here with a less conservative

Hi, Daytime Respert here with a less conservative prediction. Please understand that I only barely know what I’m talking about and this is based solely off watching stocks trade for two years, not any sort of real analysis. However, should this play out like below you will never hear the end of my expert analysis. It’ll be less annoying because we’ll be wealthy, I promise...

I predict somewhere between 3-6x upon approval. I think it moves up quickly day 1, but since we are almost completely unknown I would anticipate a good 2-3 day run before it settles backwards a bit. News should paste our name all over the world but not everybody is tracking this shit by the minute like we are. Some will find us on day 2, day 3, day X of our debut on the world stage.

Then the rate, timing, and quality of the PR’s that will follow can dictate how much more we can go in the short term. Imagine this:

EUA or approval PR (for three countries) either contains or is quickly followed with information about manufacturing increases and estimates for vial availability moving forward.

We’ve initiated our plan to save the world.

A week later it’s announced that we have presold 2022’s vials and signed deals across multiple other countries.

A week later we get breakthrough designation for cancer.

A week later we...I think you get my point.

If the momentum continues in relatively rapid succession I would think we could see a pretty crazy run up as high as 10x within a month. Not sure it’ll stay there without continued catalysts though. Like Novavax, which moved from $7 to $180 over a month or two and then dropped back to $80 at one point before cresting $300 the other day.

I believe, because of OTC trading shenanigans, our value is much greater than the current price already. Light the fuse on real, significant revenue with a worldwide spotlight and boom goes the dynamite.